Randomized controlled clinical trial of acupotomy for herniated lumbar disc: pilot study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002188

Enrollment

Registered

2017-01-04

Start date

2016-08-22

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Acupotomy) : 1. Experimental group: A total of four acupotomy treatments will be conducted(twice a week for 2 weeks). Two or three needles will be inserted 20-30 mm away from the spinous proces

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. A confirmed diagnosis of lumbar herniated disc by CT(Computed Tomography) or MRI(magnetic resonance imaging) within 5 years 2. at least one of following symptoms 1) Low back pain 2) radiating pain in low extremity 3) paraesthesia in low extremity 3. Males and females aged 20-80 years 4. Those who have no problems with language, expression and concentration 5. Able and willing to comply with intervention and follow-up evaluation 6. Voluntary agreement via written informed consent after being provided with an explanation regarding the purpose and characteristics of this study

Exclusion criteria

Exclusion criteria: Participants having one or more of the following criteria will be excluded: 1. History of hypersensitivity by acupuncture treatment 2. Patients requiring surgery because of cauda equina syndrome, or neurological symptoms such as motor and/or sensory paralysis 3. History of plate internal fixation or spinal fusion operation 4. History of neuromyopathic scoliosis or neurological degenerative disease 5. Pregnant woman, lactating woman, or woman in childbearing years who plans on being pregnant 6. Those who have a history of neurotic or psychiatric major disability or who are mentally or cognitively unstable 7. Those who are terminally ill, and need a active therapy for the illness 8. History of alcoholism or drug abuse 9. Those who have a hemorrhagic disease, uncontrolled diabetes, or cardiovascular disease, and/or factors that can affect hemostasis such as anti-coagulant or anti-platelet drug 10. Those who are considered as inappropriate for the study by researcher

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale	—

Secondary

Measure	Time frame
Oswestry Disability Index(ODI);Modified-Modified Schober Test(MMST);Quality of life(EuroQol five dimensions questionnaire; EQ-5D)	—

Countries

Korea, Republic of

Contacts

Public ContactEun Seok Kim

Dunsan Korean Medicine Hospital of Daejeon University

mybestcando@naver.com+82-42-470-9140

Outcome results